bpc 157 for bodybuilders BPC-157 athletes and injury treatment: Science, safety, and legal concerns bpc 157 for bodybuilders TLDR;

et al., Pharmaceuticals (2024) Review of BPC-157s effects on angiogenesis and cancer concerns Lee E

As long as it works, who cares?" We've seen this line of thinking before, and honestly, it can lead to compromised data and frustrating inconsistencies

Higher dosing or longer cycles use more compounded medication

A total of 79.1% were anticoagulated (59% with antivitamin K, 41% with direct anticoagulants)

Epub 2002 Nov 9

Published work on intranasal peptide delivery (for insulin analogs, calcitonin, and oxytocin) demonstrates that bioavailability for this size class without enhancers is typically in the low single-digit percent range, though these data are from different peptides with different charge profiles